Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iso-glutaminyl cyclase (QPCTL)
- Target
- QPCTL
- Molecular classification
- Enzyme, Zinc-dependent metalloenzyme
01
Overview
Iso-glutaminyl cyclase (QPCTL), also known as glutaminyl-peptide cyclotransferase-like protein or isoQC, is a zinc-dependent enzyme that catalyzes the intramolecular cyclization of N-terminal glutamine and glutamic acid residues into pyroglutamate (pGlu) at the N-terminus of proteins. This post-translational modification, called pyroglutamylation, influences protein stability and function. QPCTL plays a critical role in the maturation of chemokines and the CD47 "don't-eat-me" signal, impacting immune evasion by tumor cells. Targeting QPCTL offers therapeutic opportunities in cancer immunotherapy and inflammatory diseases.
- Other names
- Glutaminyl-peptide cyclotransferase-like proteinisoQC
02
Mechanism of action
Inhibition of iso-glutaminyl cyclase activity, preventing pyroglutamylation of target proteins
03
Biological functions
Protein maturationProtein stabilizationChemokine regulationImmune checkpoint modulationProteolysis regulation
04
Disease associations
CancerInflammationNeurodegenerative diseaseAtherosclerosis
05
Biomarkers
QPCTL expression levels as a prognostic marker in cancerQPCTL expression as a predictor of response to anti-PD-L1 immunotherapy
Beyond the preview
Go deeper on Iso-glutaminyl cyclase (QPCTL).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Iso-glutaminyl cyclase (QPCTL).